Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Original publication

DOI

10.1111/dme.13033

Type

Journal article

Journal

Diabet Med

Publication Date

12/2016

Volume

33

Pages

1744 - 1747

Keywords

Blood Glucose, Canagliflozin, Clinical Trials, Phase III as Topic, Diabetes Mellitus, Type 2, Double-Blind Method, Glycated Hemoglobin A, Humans, Hypoglycemic Agents, Insulin Resistance, Insulin-Secreting Cells, Randomized Controlled Trials as Topic, Treatment Outcome